iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Hoey Investments Inc.

Posted by Andrew Walz on Jun 14th, 2025

Hoey Investments Inc. reduced its position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 55.7% during the first quarter, Holdings Channel.com reports. The fund owned 235 shares of the financial services provider’s stock after selling 295 shares during the quarter. Hoey Investments Inc.’s holdings in iShares Biotechnology ETF were worth $30,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of IBB. VSM Wealth Advisory LLC purchased a new position in iShares Biotechnology ETF in the 4th quarter worth about $30,000. Bradley & Co. Private Wealth Management LLC purchased a new position in iShares Biotechnology ETF in the 4th quarter worth about $32,000. CX Institutional purchased a new position in iShares Biotechnology ETF in the 1st quarter worth about $32,000. Murphy & Mullick Capital Management Corp purchased a new position in iShares Biotechnology ETF in the 4th quarter worth about $35,000. Finally, GKV Capital Management Co. Inc. purchased a new position in iShares Biotechnology ETF in the 4th quarter worth about $38,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Down 0.8%

Shares of IBB opened at $128.00 on Friday. The business’s 50-day moving average price is $121.95 and its 200 day moving average price is $130.48. The stock has a market capitalization of $5.60 billion, a P/E ratio of 23.96 and a beta of 0.84. iShares Biotechnology ETF has a 1-year low of $107.43 and a 1-year high of $150.57.

iShares Biotechnology ETF Increases Dividend

The business also recently declared a dividend, which was paid on Friday, March 21st. Investors of record on Tuesday, March 18th were paid a $0.1212 dividend. The ex-dividend date was Tuesday, March 18th. This is a boost from iShares Biotechnology ETF’s previous dividend of $0.06.

About iShares Biotechnology ETF

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.